The invention is directed to compounds of Formula (I):
to pharmaceutical compositions containing such compounds and to methods of treatment using them.
该发明涉及公式(I)的化合物,涉及含有这些化合物的制药组合物以及使用它们的治疗方法。
US7951829B2
申请人:——
公开号:US7951829B2
公开(公告)日:2011-05-31
[EN] BENZIMIDAZOLE MODULATORS OF VR1<br/>[FR] MODULATEURS DES RÉCEPTEURS VR1 DÉRIVÉS DU BENZIMIDAZOLE
申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2007130780A2
公开(公告)日:2007-11-15
[EN] The invention is directed to compounds of Formula (I): to pharmaceutical compositions containing such compounds and to methods of treatment using them. [FR] L'invention concerne des composés de formule (I) :, des compositions pharmaceutiques contenant de tels composés et des procédés de traitement utilisant ceux-ci.
Benzimidazole Modulators of VR1
申请人:Player Mark R.
公开号:US20070259936A1
公开(公告)日:2007-11-08
The invention is directed to compounds of Formula (I):
to pharmaceutical compositions containing such compounds and to methods of treatment using them.